Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Cardiovascular regulation.

Artykuły w czasopismach na temat „Cardiovascular regulation”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Cardiovascular regulation”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Speer, Mei Y., i Cecilia M. Giachelli. "Regulation of cardiovascular calcification". Cardiovascular Pathology 13, nr 2 (marzec 2004): 63–70. http://dx.doi.org/10.1016/s1054-8807(03)00130-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Versteeg, Dirk H. G., Patricia Van Bergen, Roger A. H. Adan i Dick J. De Wildt. "Melanocortins and cardiovascular regulation". European Journal of Pharmacology 360, nr 1 (październik 1998): 1–14. http://dx.doi.org/10.1016/s0014-2999(98)00615-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

WEBB, D. "Endothelin and cardiovascular regulation". American Journal of Hypertension 8, nr 4 (kwiecień 1995): 18A. http://dx.doi.org/10.1016/0895-7061(95)97440-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Williamson, Jon W., i William P. Morgan. "Cardiovascular regulation: Spect neuroimaging". International Journal of Sport and Exercise Psychology 3, nr 3 (styczeń 2005): 352–62. http://dx.doi.org/10.1080/1612197x.2005.9671777.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Trinder, John, Joanna Waloszek, Michael J. Woods i Amy S. Jordan. "Sleep and cardiovascular regulation". Pflügers Archiv - European Journal of Physiology 463, nr 1 (26.10.2011): 161–68. http://dx.doi.org/10.1007/s00424-011-1041-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Russell, Fraser. "Urotensin II in cardiovascular regulation". Vascular Health and Risk Management Volume 4 (sierpień 2008): 775–85. http://dx.doi.org/10.2147/vhrm.s1983.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Sik Park, Kwon, Jang Kyu Choi i Yang Saeng Park. "Cardiovascular Regulation during Water Immersion." APPLIED HUMAN SCIENCE Journal of Physiological Anthropology 18, nr 6 (1999): 233–41. http://dx.doi.org/10.2114/jpa.18.233.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

da Costa Martins, P. A., S. Leptidis, K. Salic i L. J. De Windt. "MicroRNA Regulation in Cardiovascular Disease". Current Drug Targets 11, nr 8 (1.08.2010): 900–906. http://dx.doi.org/10.2174/138945010791591322.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Laederach-Hofmann, K., L. Mussgay i H. Ruddel. "Autonomic cardiovascular regulation in obesity". Journal of Endocrinology 164, nr 1 (1.01.2000): 59–66. http://dx.doi.org/10.1677/joe.0.1640059.

Pełny tekst źródła
Streszczenie:
Obese persons suffer from an increased mortality risk supposedly due to cardiovascular disorders related to either continuously lowered parasympathetic or altered sympathetic activation. Our cross-sectional correlation study establishes the relationship between obesity and autonomic regulation as well as salivary cortisol levels. Three patient cohorts were sampled, covering ranges of body mass index (BMI) of 27-32 (n=17), 33-39 (n=13) and above 40 kg/m(2)(n=12), and stratified for age, sex and menopausal status. Autonomic cardiovascular regulation was assessed by use of heart rate variability and continuous blood pressure recordings. Spectral analytical calculation (discrete Fourier transformation) yields indices of sympathetic and parasympathetic activation and baroreflex sensitivity. Morning salivary cortisol was concurrently collected. Contrary to expectation, BMI and waist/hip ratio (WHR) were inversely correlated with sympathetic activity. This was true for resting conditions (r=-0.48, P<0.001; r=-0.33, P<0.05 for BMI and WHR respectively) and for mental challenge (r=-0.42, P<0.01 for BMI). Resting baroreflex sensitivity was strongly related to the degree of obesity at rest (BMI: r=-0.35, P<0.05) and for mental challenge (r=-0.53, P<0.001). Salivary cortisol correlated significantly with waist circumference (r=-0.34, P=0.05). With increasing weight, no overstimulation was found but a depression in sympathetic and parasympathetic activity together with a significant reduction in baroreflex functioning and in salivary cortisol levels.
Style APA, Harvard, Vancouver, ISO itp.
10

Mingarelli, Maurizio. "The cardiovascular system renal regulation". Nephrology @ Point of Care 2, nr 1 (styczeń 2016): pocj.5000201. http://dx.doi.org/10.5301/pocj.5000201.

Pełny tekst źródła
Streszczenie:
The study of kidney physiology and cardiovascular system physiology has long unveiled several points of contract from which the existence of integrated mechanisms between the two systems has readily been inferred. In conclusion, the need is felt to conduct new studies to explore how the physiologic response to neuro-vegetative stimuli correlates to the renal function level indicated by the glomerular filtration rate (GFR) in a view to demonstrating that a decreased GFR results in cardiovascular alterations whose size is directly proportional to the same GFR reduction.
Style APA, Harvard, Vancouver, ISO itp.
11

Mancia, G., G. Grassi, A. Ferrari i A. Zanchetti. "Reflex Cardiovascular Regulation in Humans". Journal of Cardiovascular Pharmacology 7 (1985): S152—S159. http://dx.doi.org/10.1097/00005344-198500073-00018.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

McCloskey, D. I., i Erica K. Potter. "NEUROPEPTIDE Y AND CARDIOVASCULAR REGULATION". Clinical and Experimental Pharmacology and Physiology 18, nr 1 (styczeń 1991): 47–49. http://dx.doi.org/10.1111/j.1440-1681.1991.tb01376.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Bojic, Tijana, Djordje Radak, Biljana Putnikovic, Dragan Alavantic i Esma Isenovic. "Methodology of monitoring cardiovascular regulation". Vojnosanitetski pregled 69, nr 12 (2012): 1084–90. http://dx.doi.org/10.2298/vsp110707019b.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Cordes, Kimberly R., i Deepak Srivastava. "MicroRNA Regulation of Cardiovascular Development". Circulation Research 104, nr 6 (27.03.2009): 724–32. http://dx.doi.org/10.1161/circresaha.108.192872.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Ohtani, K., i S. Dimmeler. "Epigenetic regulation of cardiovascular differentiation". Cardiovascular Research 90, nr 3 (2.03.2011): 404–12. http://dx.doi.org/10.1093/cvr/cvr019.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Sessa, William C. "MicroRNA Regulation of Cardiovascular Functions". Arteriosclerosis, Thrombosis, and Vascular Biology 31, nr 11 (listopad 2011): 2369. http://dx.doi.org/10.1161/atvbaha.111.238311.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

den Ruijter, Hester M., Gerard Pasterkamp i Saskia C. A. de Jager. "Adiponectin Regulation in Cardiovascular Disease". Arteriosclerosis, Thrombosis, and Vascular Biology 34, nr 10 (październik 2014): 2180–81. http://dx.doi.org/10.1161/atvbaha.114.304380.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Fadel, Paul J. "Nitric Oxide and Cardiovascular Regulation". Hypertension 69, nr 5 (maj 2017): 778–79. http://dx.doi.org/10.1161/hypertensionaha.117.08999.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Ansakorpi, Hanna, Juha T. Korpelainen, Päivikki Tanskanen, Heikki V. Huikuri, Antero Koivula, Uolevi Tolonen, Juhani Pyhtinen, Vilho V. Myllylä i Jouko I. T. Isojärvi. "Cardiovascular Regulation and Hippocampal Sclerosis". Epilepsia 45, nr 8 (21.07.2004): 933–39. http://dx.doi.org/10.1111/j.0013-9580.2004.65003.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

RAMAGE, A., i C. VILLALON. "5-Hydroxytryptamine and cardiovascular regulation". Trends in Pharmacological Sciences 29, nr 9 (wrzesień 2008): 472–81. http://dx.doi.org/10.1016/j.tips.2008.06.009.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Taylor, Meghan M., i Willis K. Samson. "Adrenomedullin and central cardiovascular regulation". Peptides 22, nr 11 (listopad 2001): 1803–7. http://dx.doi.org/10.1016/s0196-9781(01)00522-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Andresen, Michael C., i James H. Peters. "TRPV1, Hypertension, and Cardiovascular Regulation". Cell Metabolism 12, nr 5 (listopad 2010): 421. http://dx.doi.org/10.1016/j.cmet.2010.10.004.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Diamond, BJ, H. Kim, J. DeLuca i DL Cordero. "Cardiovascular regulation in multiple sclerosis". Multiple Sclerosis Journal 1, nr 3 (listopad 1995): 156–62. http://dx.doi.org/10.1177/135245859500100304.

Pełny tekst źródła
Streszczenie:
Traditional assessments of autonomic nervous system function have depended on invasive and complex procedures. Vagal power, which is the respiratory component of heart rate variability (HRV) is an alternative and non-invasive measure for indexing autonomic nervous control of the heart In the current study, 18 multiple sclerosis (MS) and 20 healthy subjects matched with respect to age, education and intelligence served as subjects. The MS group showed significantly lower vagal power during natural and paced breathing than healthy subjects. Importantly, heart rate did not differ between the two groups. If MS patients exhibit abnormalities in mechanisms mediating cardiac parasympathetic control, the impact on quality of life and vulnerability to adverse cardiac events need to be further evaluated. The results of this study may have implications with respect to the feasibility of using HRV as both a diagnostic and prognostic tool for evaluating parasympathetic nervous system dysfunction and in providing valuable information for developing more effective treatment and rehabilitation strategies.
Style APA, Harvard, Vancouver, ISO itp.
24

Pedrazzini, Thierry, Hans R. Brunner i Bernard Waeber. "Neuropeptide Y and cardiovascular regulation". Current Opinion in Nephrology and Hypertension 2, nr 1 (styczeń 1993): 106–13. http://dx.doi.org/10.1097/00041552-199301000-00016.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Marshall, J. M. "Peripheral chemoreceptors and cardiovascular regulation". Physiological Reviews 74, nr 3 (1.07.1994): 543–94. http://dx.doi.org/10.1152/physrev.1994.74.3.543.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Török, Tamas, i László Rudas. "Aging and cardiovascular autonomic regulation". Canadian Journal of Anaesthesia 44, nr 6 (czerwiec 1997): 677–78. http://dx.doi.org/10.1007/bf03015457.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Mikulášková, B., L. Maletínská, J. Zicha i J. Kuneš. "The role of food intake regulating peptides in cardiovascular regulation". Molecular and Cellular Endocrinology 436 (listopad 2016): 78–92. http://dx.doi.org/10.1016/j.mce.2016.07.021.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Shirasaka, Tetsuro, Mayumi Takasaki i Hiroshi Kannan. "Cardiovascular effects of leptin and orexins". American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 284, nr 3 (1.03.2003): R639—R651. http://dx.doi.org/10.1152/ajpregu.00359.2002.

Pełny tekst źródła
Streszczenie:
Leptin, the product of the obgene, is a satiety factor secreted mainly in adipose tissue and is part of a signaling mechanism regulating the content of body fat. It acts on leptin receptors, most of which are located in the hypothalamus, a region of the brain known to control body homeostasis. The fastest and strongest hypothalamic response to leptin in ob/ob mice occurs in the paraventricular nucleus, which is involved in neuroendocrine and autonomic functions. On the other hand, orexins (orexin-A and -B) or hypocretins (hypocretin-1 and -2) were recently discovered in the hypothalamus, in which a number of neuropeptides are known to stimulate or suppress food intake. These substances are considered important for the regulation of appetite and energy homeostasis. Orexins were initially thought to function in the hypothalamic regulation of feeding behavior, but orexin-containing fibers and their receptors are also distributed in parts of the brain closely associated with the regulation of cardiovascular and autonomic functions. Functional studies have shown that these peptides are involved in cardiovascular and sympathetic regulation. The objective of this article is to summarize evidence on the effects of leptin and orexins on cardiovascular function in vivo and in vitro and to discuss the pathophysiological relevance of these peptides and possible interactions.
Style APA, Harvard, Vancouver, ISO itp.
29

Li, Xiang-Nong. "Hepato-cardiovascular response and its regulation". World Journal of Gastroenterology 11, nr 5 (2005): 676. http://dx.doi.org/10.3748/wjg.v11.i5.676.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Bauersachs, Johann, i Thomas Thum. "Biogenesis and Regulation of Cardiovascular MicroRNAs". Circulation Research 109, nr 3 (22.07.2011): 334–47. http://dx.doi.org/10.1161/circresaha.110.228676.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Hirata, Yukio. "Recent Advance in Cardiovascular Regulation Research". Japanese Circulation Journal 57, supplementIV (1993): 1131–35. http://dx.doi.org/10.1253/jcj.57.supplementiv_1131.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Head, Geoffrey A. "Baroreflexes and Cardiovascular Regulation in Hypertension". Journal of Cardiovascular Pharmacology 26, nr 2 (1995): S7–16. http://dx.doi.org/10.1097/00005344-199512020-00002.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Hirooka, Yoshitaka, Yoji Sagara, Takuya Kishi i Kenji Sunagawa. "Oxidative Stress and Central Cardiovascular Regulation". Circulation Journal 74, nr 5 (2010): 827–35. http://dx.doi.org/10.1253/circj.cj-10-0153.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

FUXE, K., J. A. AGUIRRE, L. F. AGNATI, G. EULER, P. HEDLUND, R. COVEÑAS, M. ZOLI, B. BJELKE i P. ENEROTH. "Neuropeptide Y and Central Cardiovascular Regulation." Annals of the New York Academy of Sciences 611, nr 1 Central and P (listopad 1990): 111–32. http://dx.doi.org/10.1111/j.1749-6632.1990.tb48926.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Porta, Alberto, Marco Di Rienzo, Niels Wessel i Juergen Kurths. "Addressing the complexity of cardiovascular regulation". Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences 367, nr 1892 (27.02.2009): 1215–18. http://dx.doi.org/10.1098/rsta.2008.0292.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Bruneau, Benoit G. "Epigenetic Regulation of the Cardiovascular System". Circulation Research 107, nr 3 (6.08.2010): 324–26. http://dx.doi.org/10.1161/res.0b013e3181f17dfe.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Guo, Deng-Fu, John J. Reho, Donald A. Morgan i Kamal Rahmouni. "Cardiovascular Regulation by the Neuronal BBSome". Hypertension 75, nr 4 (kwiecień 2020): 1082–90. http://dx.doi.org/10.1161/hypertensionaha.119.14373.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Rocchini, A. P. "Cardiovascular regulation in obesity-induced hypertension." Hypertension 19, nr 1_Suppl (1.01.1992): I56. http://dx.doi.org/10.1161/01.hyp.19.1_suppl.i56.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Duschek, Stefan, Jana Wörsching i Gustavo A. Reyes del Paso. "Autonomic cardiovascular regulation and cortical tone". Clinical Physiology and Functional Imaging 35, nr 5 (31.07.2014): 383–92. http://dx.doi.org/10.1111/cpf.12174.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Suzuki, Jun-ichi, Mitsuaki Isobe, Ryuichi Morisihita i Ryozo Nagai. "Genetic Regulation for Inflammatory Cardiovascular Disease". Journal of Molecular and Cellular Cardiology 45, nr 4 (październik 2008): S6—S7. http://dx.doi.org/10.1016/j.yjmcc.2008.09.610.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

BENNETT, T., i S. M. GARDINER. "Involvement of vasopressin in cardiovascular regulation". Cardiovascular Research 19, nr 2 (1.02.1985): 57–68. http://dx.doi.org/10.1093/cvr/19.2.57.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Fritsche, R., i A. Jacobsson. "Ontogeny of cardiovascular regulation in amphibians". Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 124 (sierpień 1999): S31. http://dx.doi.org/10.1016/s1095-6433(99)90120-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Head, Geoffrey A. "Baroreflexes and Cardiovascular Regulation in Hypertension". Journal of Cardiovascular Pharmacology 26 (1995): S7–16. http://dx.doi.org/10.1097/00005344-199506262-00002.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Laederach-Hofmann, Kurt, Lutz Mussgay i Heinz Rüddel. "293 Autonomic cardiovascular regulation in obesity". International Journal of Psychophysiology 30, nr 1-2 (wrzesień 1998): 114–15. http://dx.doi.org/10.1016/s0167-8760(98)90292-6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Weaver, L. C., i H. V. Sparks. "Neural Regulation of the Cardiovascular System". Annual Review of Physiology 50, nr 1 (październik 1988): 509–10. http://dx.doi.org/10.1146/annurev.ph.50.030188.002453.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Porter, J. P., i M. J. Brody. "Spinal vasopressin mechanisms of cardiovascular regulation". American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 251, nr 3 (1.09.1986): R510—R517. http://dx.doi.org/10.1152/ajpregu.1986.251.3.r510.

Pełny tekst źródła
Streszczenie:
Extrahypothalamic vasopressin-containing neurons have been implicated in the central neural control of the cardiovascular system. In the present study we investigated the possibility that vasopressinergic neurons arising from the paraventricular nucleus (PVN) and terminating in the spinal cord are involved in the regulation of vasomotor functions. Vasopressin (1-17 pmol) was injected into the spinal subarachnoid space of conscious rats instrumented with Doppler flow probes and indwelling intrathecal catheters. The peptide produced a dose-related increase in arterial pressure accompanied by vasoconstriction in the mesenteric, renal, and hindquarter vascular beds. Pretreatment, intrathecally, with 0.5 nmol of the vasopressin antagonist d(CH2)5Me(Tyr)AVP completely prevented the increase in arterial pressure expected after subsequent intrathecal injection of vasopressin. However, the changes in arterial pressure and vascular resistances produced by stimulation of the PVN were not affected by the intrathecal antagonist. Stimulation of the PVN in Brattleboro rats, which lack hypothalamic and spinal vasopressin, produced hemodynamic responses similar to those produced in Long-Evans control rats. Taken together, these data suggest that spinal vasopressin can act within the spinal cord to alter vasomotor functions; however, the hemodynamic effects evoked by stimulation of the PVN do not appear to depend on spinal vasopressinergic mechanisms.
Style APA, Harvard, Vancouver, ISO itp.
47

Shoemaker, J. Kevin. "Peripheral Chemoreceptor Contributions to Cardiovascular Regulation". Heart Drug 4, nr 4 (2004): 190–200. http://dx.doi.org/10.1159/000082190.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Hall, J. E. "Integration and regulation of cardiovascular function." Advances in Physiology Education 277, nr 6 (grudzień 1999): S174. http://dx.doi.org/10.1152/advances.1999.277.6.s174.

Pełny tekst źródła
Streszczenie:
New methods in molecular biology and genetics have made possible many of the dramatic advances in physiological research that have occurred in recent years. For those of us who spend most of our time in the research laboratory, it si sometimes difficult to avoid a research-oriented, reductionist mind-set when discussing physiology with students. This article illustrates, with a few examples, the importance of conveying a "big picture" conceptual framework before discussing the details of cardiovascular physiology. Also, I have chosen examples from cardiac output and blood pressure regulation that show the importance of discussing cardiovascular physiology in terms of feedback control systems and integrating information from other areas, such as renal and endocrine physiology. Finally, I have highlighted the importance of two principles that I believe are often underemphasized in teaching physiology: mass balance and time dependence of physiological control systems.
Style APA, Harvard, Vancouver, ISO itp.
49

Share, L. "Role of vasopressin in cardiovascular regulation." Physiological Reviews 68, nr 4 (październik 1988): 1248–84. http://dx.doi.org/10.1152/physrev.1988.68.4.1248.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Minson, Jane, John Chalmers, Guy Drolet, Vimal Kapoor, Ida Llewellyn-Smith, Eric Mills, Margaret Morris i Paul Pilowsky. "Central serotonergic mechanisms in cardiovascular regulation". Cardiovascular Drugs and Therapy 4, nr 1 (styczeń 1990): 27–32. http://dx.doi.org/10.1007/bf00053423.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii